Livzon Pharmaceutical Group Inc. at its Extraordinary General Meeting of 2022 held on 21 June 2023, approved Election and nomination of Xu Guoxiang, executive director, as non-independent directors, Election and nomination of Huang Jinhua as independent directors and Election of Huang Huamin, Tang Yin as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.41 CNY | +0.33% | -3.50% | +12.57% |
May. 14 | Livzon Pharmaceutical Group Cancels Share Options | MT |
May. 14 | Livzon Pharmaceutical Declares Final Dividend for 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.57% | 4.48B | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. Announces Directorate Appointments